MYCIO Wealth Partners’s Alexion Pharmaceuticals ALXN Stock Holding History

MYCIO Wealth Partners’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-41	Closed	-$5K	–	736
2016 Q3	$5K	Buy	41 +25	+156%	+$3.22K	﹤0.01%	672
2016 Q2	$2K	Buy	+16	New	+$2.27K	﹤0.01%	931
2016 Q1	–	Sell	-150	Closed	-$29K	–	915
2015 Q4	$29K	Hold	150	–	–	0.01%	363
2015 Q3	$23K	Hold	150	–	–	﹤0.01%	424
2015 Q2	$27K	Hold	150	–	–	0.01%	388
2015 Q1	$26K	Hold	150	–	–	0.01%	371
2014 Q4	$28K	Hold	150	–	–	0.01%	352
2014 Q3	$25K	Sell	150 -100	-40%	-$16.4K	0.01%	337
2014 Q2	$39K	Hold	250	–	–	0.01%	295
2014 Q1	$38K	Buy	+250	New	+$39.8K	0.01%	286

Other funds holding ALXN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

MYCIO Wealth Partners's ALXN Position: Q4 2016 in Review

MYCIO Wealth Partners sold out of Alexion Pharmaceuticals (ALXN) in Q4 2016, closing a stake of 41 shares — an estimated $5K sold.

MYCIO Wealth Partners first reported a position in ALXN in Q1 2014 and held it in 10 quarters. The position peaked at $39K in Q2 2014. 548 funds tracked by Wall St. Rank hold ALXN as of Q4 2016.

MYCIO Wealth Partners reported no remaining Alexion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
MYCIO Wealth Partners sold 41 Alexion Pharmaceuticals shares in Q4 2016, an estimated $5K.
MYCIO Wealth Partners first reported a position in Alexion Pharmaceuticals in Q1 2014 and held it in 10 quarters.
MYCIO Wealth Partners's Alexion Pharmaceuticals position peaked at $39K in Q2 2014.
548 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2016.

Based on MYCIO Wealth Partners's 13F filing for Q4 2016, filed 1 Feb 2017.